Theravance Biopharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $-140.7M | — |
| FY2012 | — | $-7.0M | $0 |
| FY2013 | — | $-17.0M | $0 |
| FY2014 | — | $289.8M | $277.5M |
| FY2015 | — | $243.1M | $112.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $-140.7M | — |
| FY2012 | — | $-7.0M | $0 |
| FY2013 | — | $-17.0M | $0 |
| FY2014 | — | $289.8M | $277.5M |
| FY2015 | — | $243.1M | $112.7M |